Data from cache
This film tells the story of the journey from research to practice for self-injectable contraception in Malawi. From 2015 to 2017, FHI 360 and the University of Malawi conducted a study in Malawi to investigate the effectiveness of self-administered depot medroxyprogesterone acetate (DMPA-SC) . The study found that self-injection led to a more than 50% increase in continuous DMPA-SC pregnancy protection through 12 months, compared to provider-administered injection. As a result of the study findings, the Ministry of Health in Malawi are now rolling out DMPA-SC and self-injection in 7 districts across the country, with plans for national scale-up by 2020. This self-injectable contraception puts power in the hands of girls and women to make decisions and take control of their own health, accelerating universal access to sexual and reproductive healthcare.